Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
2.920
-0.150 (-4.89%)
At close: Dec 17, 2025, 4:00 PM EST
2.930
+0.010 (0.34%)
After-hours: Dec 17, 2025, 4:13 PM EST

Alterity Therapeutics Revenue

In the fiscal year ending June 30, 2025, Alterity Therapeutics had annual revenue of 5.44M AUD with 35.32% growth. Alterity Therapeutics had revenue of 3.83M in the half year ending June 30, 2025, with 150.44% growth.

Revenue (ttm)
5.44M AUD
Revenue Growth
+35.32%
P/S Ratio
16.14
Revenue / Employee
604,324 AUD
Employees
9
Market Cap
57.54M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20255.44M1.42M35.32%
Jun 30, 20244.02M102.95K2.63%
Jun 30, 20233.92M-1.21M-23.56%
Jun 30, 20225.12M783.93K18.06%
Jun 30, 20214.34M--
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro